chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Shingles on my face; This is a spontaneous report from a contactable consumer (patient herself). A 51-years-old non pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Batch/Lot number: ER8727, Expiry date was not reported), dose 2 via an unspecified route of administration, administered in Arm Left on 08Apr2021 14:00 (Age at vaccination 51-years-old) as dose 2, single for covid-19 immunisation. The patient was not pregnant at time of vaccination. The patient medical history was not reported. Concomitant medications included gabapentin (GABAPENTIN), bupropion hydrochloride (WELLBUTRIN) taken for an unspecified indication, start and stop date were not reported. The patient had no known allergies. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Batch/Lot number: EN6199, Expiry date was not reported), dose 1 via an unspecified route of administration, administered in Arm Left on 11Mar2021 16:00 (Age at vaccination 51-years-old) as dose 1, single for covid-19 immunisation. On 12Apr2021 12:00, the patient had experienced 4 days after my 2nd vaccine, I started to present Shingles on my face. Events required visit to doctor or other healthcare professional office/clinic visit. The patient received anti-viral meds and prednisone as treatment for the event. Therapeutic measures were taken for the events. The patient had not received any other vaccine within 4 weeks. Patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. The patient received gabapentin, wellbutrin other medications in two weeks. The outcome of event was recovering.  No follow-up attempts are possible. No further information is expected.
got tested and tested positive; Got tested and tested positive; lethargic; This is a spontaneous report from a contactable consumer. This consumer reported similar events for two patients (husband and wife). This is the second of two reports (for the husband).  A 74-year-old male patient received the first dose of BNT162B2 (Pfizer-BIONTECH Covid-19 Vaccine; lot number and expiry date were not reported), via an unspecified route of administration on 04Jan2021 as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, reported as two days after, the patient was lethargic. A week ago on an unspecified date, reported as past Monday, the patient had no cough, no fever, received azithromycin, got tested and tested positive. The patient underwent laboratory tests and procedures which included COVID-19 test: positive on an unspecified date. Outcome of the events was unknown.  No follow-up attempts are possible. Information about the lot/batch cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021034433 same reporter, same drug/event, different patient
Expired vials were used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vials were used) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 049E21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vials were used). On 05-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Expired vials were used) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided by the reporter. No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 19-Nov-2021: Non-Significant follow up appended secondary reporter information added.
Headache, Myalgia & Diarrhea Narrative: Lost work time.
Patient came in and received her second dose of SHINGRIX on 4/10/19 (1st dose was 1/23/19). Patient came into pharmacy on 4/12 and presented with a red, round spot on her arm that was warm and sore. This spot was about 4 inches below injection site.
Since my second vaccine I have had a change in my taste and smell. The best example is eggs ? I love eggs they?re one of my favorite foods and I eat them frequently, but now they have a bad taste and smell. I?ve noticed it with some other foods as well, such as chocolate chip cookies and this packaged rice. I think the common ingredient is sulfur.
The next day after injection, small red circle appeared where injection was given. It was red, swollen, and warm to touch. Sore arm was noted as well. Red mark continued to get bigger for 4+ days until it eventually went away.
AFEBRILE SEIZURE, UNUSUAL MOVEMENTS; RESTLESS NIGHT; WENT TO ER ON 6-11-15 FOR LEG RIGIDNESS, MOUTH FOAMING, DIFFICULTY WAKING UP.
ringing in my ears; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (ringing in my ears) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced TINNITUS (ringing in my ears). At the time of the report, TINNITUS (ringing in my ears) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment information was provided.  Very limited information regarding the event has been provided at this time.  Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Sender's Comments: Very limited information regarding the event has been provided at this time.  Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Pulse pounded hard and fast. BP up to 143. (Normal 115) No treatment  5 minutes after shot until about 7 hours later
Pt. received vaccines on 11/03/2004. Mom reported pt had redness around the injection site. Pt rechecked in office dx with allergic reaction. Instructed to give Benadryl.
Site: Pain at Injection Site-Mild, Additional Details: patient had no brusing, swelling, tingling after the vaccination.  pain is limited directly to the injection site and does not radiate through arm or shoulder.  patient indicated that her arm feels "restless".  no new medications besides aleeve for the pain. the pain is not positional - it is jsut always tender
The pt experienced a hive the size of a dime at the injection site within 5 minutes post vax. No other symptoms observed. Benadryl was given. Parent was given instructions to follow-up if symptoms worsen.
The pt had a PMH of ITP in 1998 during his adjuvant chemotherapy for colorectal cancer. , treated with IGIV. Two weeks, post vax, he presented with recurrent ITP. The pt complained of bruising. He was treated with WinRho, prednisone and platelet transfusion. He is currently taking 60mg of prednisone. In 17 years of clinical practice, I don't ever recall seeing ITP related to influenza vaccine. Seeing 2 pts in the same week was more than a coincidence for me. I thought this would be of interest to you.
Hallucination type drams and headache during the night, sick and fatigued the following days. A few days later noticed tinnitus which I didn?t immediately connect with the vaccine. Unresolved and seems to be increasing. No prior hearing liss
Patient complained of being dizzy and having anxiety after immunization. Patient cleared by EMS. Patient advised to call 911 or go to the nearest emergency room for any additional issues as needed. Also advised to sign up for v-safe.
Patient was injected with an empty sterile/unused needle that had not yet been drawn up with vaccine prior to receiving the actual dose.
Pain, weakness, inablilty to move right upper extremities (from neck to wrist), chills, sweating, dizziness, visual disturbance.
Information had been received on 20-APR-2017 from a lawyer regarding a case in litigation. It was alleged in litigation that a female patient of unknown age was inoculated with ZOSTAVAX vaccine (dose, route, site of administration, lot # and expiration date were not provided) on or about 02-MAR-2008 at a health department facility, as recommended for routine adult health maintenance for the prevention of shingles. The patient's medical history, concurrent conditions and concomitant medication were not provided. The lawyer reported, the ZOSTAVAX vaccine did not prevent shingles as intended, but rather caused patient to contract a persistent strain of Herpes Zoster. On or about 05-JUL2016, the patient was treated by a physician at a medical facility (internal medicine) for a painful rash that was diagnosed as shingles.  As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, pain and suffering and other damages. Additional information has been requested.
Vaccine site with 10x10 cm raised red warm area of induration and pain. 1/19/2007 Rocephin IM and prescription for PO Keflex. ER with increase size redness. 1/20/07 hospitalized with IV Vancomycin and home on PO Bactrim. 02/28/07-records received from facility for DOS 01/21-01/21/07 DC DX: left leg cellulitis versus vaccine reaction.  HX of Present illness:redness, swelling, induration of left thigh. No fever.
no adverse event reported by patient, no symptoms or signs. reporting that dose was given after 11 days after beyond use date and was stored in the refrigerator with average temperature of 38 degrees.
Left Axillary Mono Neuropathy, Hospitalization needed and Physical Therapy and pain injections. Patient stills has limited mobility in Left arm, unable to lift it in any way.
This spontaneous report was received from a registered nurse, referring to a patient of unknown age and gender. Information about the patient's medical history, concurrent conditions and concomitant medication was not reported. On an unspecified date, the patient may have received an improperly stored dose of either: -RECOMBIVAX HB (lot # L040458  expiration date: 04-FEB-18; L044707 expiration date: 06-OCT-2018) -PEDVAXHIB (lot # M027884 expiration date: 19-APR-2019; lot # M027881  expiration date: 13-APR-2019) -ROTATEQ (lot # M026491 expiration date 01-FEB-2018; lot # M034799 expiration date 28-FEB-2018) -GARDASIL 9 (lot # M017983  expiration date: 30-MAY-2018). Route and dosage unknown for prophylaxis for all vaccines except for ROTATEQ (orally; dosage unknown) for prophylaxis. The vaccines were exposed to 14-16 °C for 9 hours. No previous excursions. A data logger was used. No adverse effects were reported. Additional information has been requested.
Extreme swelling all upper left arm around injection site. Started 6 days after shot was given. Lasted 5 days
had flush feeling (much like injection during CT scan); Within hour my ears felt hot and turned bright red Subsided within hour.; Ate supper, Went to bed, upon waking in nite experienced imbalance; vertigo; Neck pain; headache; nausea; This is a spontaneous report from a contactable consumer (patient). A 64-year-old female non-pregnant patient received first dose BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9264, Solution for injection), via an unspecified route of administration in the left arm on 29Jan2021 (at the age of 64-years-old) as a single dose for COVID-19 vaccination. Medical history included CAD (coronary artery disease), Irregular heart rhythm, BPPV, degenerative disc disease, anxiety, ptsd (post-traumatic stress disorder), pre diabetic, Allergies to food, chemical and sensitivities and med and sensitivites. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient had not received any other vaccine within 4 weeks prior to the vaccine. Concomitant medications were not reported. Upon receiving injection, on 30Jan2021, patient had flush feeling (much like injection during CT scan). Within hour her ears felt hot and turned bright red Subsided within hour. After supper, went to bed, upon waking in night experienced imbalance. Laying back down experieced vertigo (what she thought was a BPPV episode, a prior cond) but she couldnt figure out which side to treat, she performed maneuver. But did not resolve. She was remaining off balance and spinny even being upright with movement of head or eyes. Neck pain and headache residual nausea. About 12 hours after injection. Upside, her arm doesnt hurt. The patient did not receive any treatment for the events. No seriousness criteria was reported. The patient underwent lab tests and procedures which included computerised tomogram and results are unknown. The outcome of events was unknown.
Information has been received from a Nurse Practitioner concerning a 13 month old male patient with no known drug allergies or medical history who on 13-APR-2009 was vaccinated with MMR II (lot # 659706/0266X). Concomitant suspect therapy included VARIVAX (lot # 661651/0989X). On 14-APR-2009 the patient developed hives. The patient was examined in the emergency room on 14-APR-2009 for the treatment for a bite from a bat and released that day. The patient was administered a rabies vaccine and rabies immune globulin (manufacturer unknown). The patient developed hives 20 minutes later and was treated with KENALOG, DECADRON 4 mg IV and BENADRYL. The next week the patient was administered a different brand of rabies vaccine and also developed hives 20 minutes later. Allergy tests were conducted on the patient and it was determined that he did not have an allergy to rabies vaccine. The patient was administered a third and fourth dose of rabies vaccine with out any reaction. The patient's mother did state that he had had recurrent rashes but rashes were not seen by physician. The mother stated one time the rash looked like hives and another time it appeared as red spots on his stomach. On an unknown date the patient recovered. Additional information has been requested.
Itching started on my face, palms, head, back and scalp then it went to my arm. Then it went to my torso and my boobs, Treatment started taking over the counter Pepcid Benadryl 50mg 2-3 times a day to stop the itching it didn't really help just made me sleepy. Doctor told me to try Zyrtec didn't help- it has antihistamine qualities Tried Claritin with Benadryl and that didn't help.
This spontaneous report was received from a registered nurse referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 07-NOV-2012, the patient was vaccinated with the second dose of GARDASIL (lot # 0555AE with expiration date of 14-DEC-2014; strength, dose, route and anatomical location were not provided), for prophylaxis. Subsequently, on 17-JAN-2013, the patient was vaccinated with the third dose of GARDASIL (lot # H010428 with expiration date of 20-JAN-2015; strength, dose, route and anatomical location were not provided), also for prophylaxis. It was reported that the interval between the second and third dose of GARDASIL was administered too early. Additionally, the registered nurse stated that there was only a ten week interval between the second and third dose of GARDASIL. Additional information has been requested.
Rash in the hands, legs, chest, groin, axilla, stomach. Ate pizza afterwards.
This case was reported by a consumer via call center representative and described the occurrence of erythema of extremities in a adult female patient who received SHINGRIX for prophylaxis. In May 2018, the patient received the 1st dose of SHINGRIX. In May 2018, 1 day after receiving SHINGRIX, the patient experienced erythema of extremities, pain in arm and extremities hot feeling of. The patient was treated with topical Steroid Cream. In May 2018, the outcome of the erythema of extremities, pain in arm and extremities hot feeling of were recovered/resolved. It was unknown if the reporter considered the erythema of extremities, pain in arm and extremities hot feeling of to be related to SHINGRIX. Additional details were received as follows: The age at vaccination was not reported. The patient received a dose of SHINGRIX in left arm. Batch number, expiry date and dose of vaccine were not reported. In early May 2018, the reporter received a dose of SHINGRIX in left arm, exact date was not reported. On the day of vaccination, the patient experienced soreness in left arm. A day after vaccination, the patient experienced redness and heat in left arm. The patient saw her dermatologist and he was given steroid cream. The patient noted that the events were began to improve after using steroid cream for three days. The events were completely resolved within five days, the dates were not reported. The patient had denied permission to contact their physician. The reporter did not wish to be contacted for any further follow up. The reporter could not provide full address for the vaccine facility. The reporter could not provide the name of the pharmacist who administered the vaccine. The reporter declined to provide complete address details.
right armpit and right collar bone ball half the size of an egg. if you push you can feel 4 marble sized bumps. Pfizer on 1st dose December 30th, second dose January 20th.
pt recv vax had URI sx 1wk later;seen post vax day 9 for fever,sore throat,irritability,exam nl,neg strep cult,day 11 had blanching erythematous macular rash trunk,URI sx otherwise exam nl;
Red, hot, swollen , hard lump with pain and itching about 12 hrs after vaccine Very swollen lymph nodes in axilla of that arm 36 hrs after vaccine Body aches, headache, chills, GI upset About 12-26 hrs after vaccine.
Initial information received on 22-Oct-2018 regarding an unsolicited valid serious case received from a nurse via other company (Pfizer). This case involves a 17 years old male patient who experienced left arm cellulitis, fever, chills and sweat, while he received vaccines TRUMENBA and MENACTRA. The patients past medical history and family history were not provided. The patient did not receive any concomitant medication. On 24-Sep-2018, the patient received injection of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE lot number, expiry date and dose not reported via unknown route in unknown administration site. On 24-Sep-2018, the patient received a first dose of suspect TRUMENBA not produced by Sanofi Pasteur lot W09937, expiry date Jan 2020 via unknown route in the left arm. On 25-Sep-2018, the patient developed a serious left arm cellulitis (cellulitis) one day following the administration of MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE and following the administration of TRUMENBA. This event was assessed as Important medical event. On 24-Sep-2018, the patient developed a non-serious fever (pyrexia) same day, late night following the administration of MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE and following the administration of TRUMENBA. On 24-Sep-2018, the patient developed a non-serious chills same day, late night following the administration of MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE and following the administration of TRUMENBA. On 24-Sep-2018, the patient developed a non-serious sweat (hyperhidrosis) same day, late night following the administration of MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE and following the administration of TRUMENBA. Relevant laboratory test results included- Body temperature - On 25-Sep-2018: 97.6 Relevant tests were not reported. Final diagnosis was sweat, chills, fever and left arm cellulitis. The patient was treated with Keflex- 500mg capsule one capsule twice daily by mouth, Prednisone- A weaning dose of 30mg, 20mg and 10mg for 3 days each. These are tablets the patient took by mouth. Benadryl-Over the counter dose of 25mg to 50mg as needed. The patient outcome is reported as Recovered / Resolved on an unknown date for fever, as Recovered / Resolved on an unknown date for chills, as Recovered / Resolved on an unknown date for sweat and as Recovered / Resolved on an unknown date for left arm cellulitis. The reporter assessed the causal relationship with suspect vaccines as Related. List of documents held by sender- none.; Sender's Comments: This case concerns a 17-year-old patient who developed left arm cellulitis, fever, chills and sweat after vaccination with TRUMENBA and MENACTRA. The time to onset is compatible. However, there is no information regarding the patient's condition at the time of vaccination and the etiology for cellulitis. Cellulitis occurred at other company vaccinated arm. There is a possibility that the infection is due to a faulty vaccination procedure that introduced skin organisms into the patient. Moreover, multiple vaccine use preceded the events. Based upon the reported information, the role of an individual vaccine cannot be assessed.
Stroke; still couldn't walk; This is a spontaneous report from a non-contactable consumer reported for the other uncle. A male patient of unspecified age received the 2nd dose of bnt162b2 (Pfizer-BioNTech COVID-19 vaccine), via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization. Medical history and concomitant medications were unknown. The patient previously received the 1st dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) for COVID-19 immunization. The reporter's family, personally had 3 people experience the stroke within 1st 24 hours after 2nd dose. The patient (reporter's other uncle) was 59 or 60 (not clarified). The patient had a stroke and he still couldn't walk. Outcome of the events was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected. ; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101335048 different  patient, same drug, different event;US-PFIZER INC-202101335052 different  patient, same drug, different event
HERPES ZOSTER IN A PREVIOUSLY VACCINATED CHILD INVOLVING Left T5-7 AND C5 DERMATOMES.  THE RASH STARTED 11/30/06 AND RASH LASTED >8 WEEKS.  CHILD WAS TREATED WITH ACYCLOVIR 1/22/07-1/27/07.  LESION SPECIMENS WERE COLLECTED 1/22/07 AND WERE POSITIVE FOR VZV VACCINE STRAIN.  THE RASH RESOLVED WITHOUT FURTHER COMPLICATION.
headache started 1 hour after shot   persistent x 8 days  no history headaches
Pt. was requested by school to recieve an MMR due to lack of proof for second MMR. MMR given on 8/26/05 and patient comes in today c/o stiff neck.